Characterization of the bas-congo virus glycoprotein and its function in pseudotyped viruses

Journal of Virology

Volumn 87, Issue 17, 2013, Pages 9558-9568

  Steffen, Imke ^a,b   Liss, Nathan M ^a,b   Schneider, Bradley S ^c   Fair, Joseph N ^c   Chiu, Charles Y ^b,d   Simmons, Graham ^a,b  

^a BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c METABIOTA INC   (United States)

^d ABBOTT DIAGNOSTICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; LECTIN; MANNOSE; VIRUS FUSION PROTEIN; VIRUS GLYCOPROTEIN;

ACIDIFICATION; ANIMAL CELL; ARTICLE; BAS CONGO VIRUS; BIOSAFETY; CELL ADHESION; CELL CULTURE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEMBRANE FUSION; MOUSE; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN BINDING; PSEUDOTYPING; RAT; RHABDOVIRUS; SEQUENCE HOMOLOGY; TARGET CELL; TEMPERATURE; VESICULAR STOMATITIS VIRUS; VIRAL TROPISM; VIRUS ENTRY; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CONGO; CRICETINAE; HUMANS; MEMBRANE FUSION; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; RHABDOVIRIDAE; RHABDOVIRIDAE INFECTIONS; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 84883278385     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01183-13     Document Type: Article

References (41)

1. Grard G, Fair JN, Lee D, Slikas E, Steffen I, Muyembe JJ, Sittler T, Veeraraghavan N, Ruby JG, Wang C, Makuwa M, Mulembakani P, Tesh RB, Mazet J, Rimoin AW, Taylor T, Schneider BS, Simmons G, Delwart E, Wolfe ND, Chiu CY, Leroy EM. 2012. A novel rhabdovirus associated with acute hemorrhagic fever in central Africa. PLoS Pathog. 8:e1002924. doi:10.1371/journal.ppat.1002924.
2. Kuzmin IV, Novella IS, Dietzgen RG, Padhi A, Rupprecht CE. 2009. The rhabdoviruses: biodiversity, phylogenetics, and evolution. Infect. Genet. Evol. 9:541-553.
3. WHO. 2013. Rabies fact sheet n°99. WHO, Geneva, Switzerland.
4. Hoffmann B, Beer M, Schutze H, Mettenleiter TC. 2005. Fish rhabdoviruses: molecular epidemiology and evolution. Curr. Top. Microbiol. Immunol. 292:81-117.
5. Rodriguez LL. 2002. Emergence and re-emergence of vesicular stomatitis in the United States. Virus Res. 85:211-219.
6. Dimitrov DS. 2004. Virus entry: molecular mechanisms and biomedical applications. Nat. Rev. Microbiol. 2:109-122.
7. Sun X, Belouzard S, Whittaker GR. 2008. Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein. J. Biol. Chem. 283:6418-6427.
8. Roche S, Albertini AA, Lepault J, Bressanelli S, Gaudin Y. 2008. Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited. Cell. Mol. Life Sci. 65:1716-1728.
9. Schibli DJ, Weissenhorn W. 2004. Class I and class II viral fusion protein structures reveal similar principles in membrane fusion. Mol. Membr. Biol. 21:361-371.
10. Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, Lee B. 2005. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 436:401-405.
11. Salvador B, Zhou Y, Michault A, Muench MO, Simmons G. 2009. Characterization of Chikungunya pseudotyped viruses: identification of refractory cell lines and demonstration of cellular tropism differences mediated by mutations in E1 glycoprotein. Virology 393:33-41.
12. Salvador B, Sexton NR, Carrion R, Jr, Nunneley J, Patterson JL, Steffen I, Lu K, Muench MO, Lembo D, Simmons G. 2013. Filoviruses utilize glycosaminoglycans for their attachment to target cells. J. Virol. 87:3295- 3304.
13. Whitt MA. 2010. Generation of VSV pseudotypes using recombinant DeltaG-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines. J. Virol. Methods 169:365-374.
14. Pohlmann S, Baribaud F, Lee B, Leslie GJ, Sanchez MD, Hiebenthal-Millow K, Munch J, Kirchhoff F, Doms RW. 2001. DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus. J. Virol. 75:4664-4672.
15. Pohlmann S, Zhang J, Baribaud F, Chen Z, Leslie GJ, Lin G, Granelli-Piperno A, Doms RW, Rice CM, McKeating JA. 2003. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J. Virol. 77:4070-4080.
16. Shakin-Eshleman SH, Remaley AT, Eshleman JR, Wunner WH, Spitalnik SL. 1992. N-linked glycosylation of rabies virus glycoprotein. Individual sequons differ in their glycosylation efficiencies and influence on cell surface expression. J. Biol. Chem. 267:10690-10698.
17. Robertson JS, Etchison JR, Summers DF. 1976. Glycosylation sites of vesicular stomatitis virus glycoprotein. J. Virol. 19:871-878.
18. Vigerust DJ, Shepherd VL. 2007. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol. 15:211-218.
19. Feldmann H, Volchkov VE, Volchkova VA, Stroher U, Klenk HD. 2001. Biosynthesis and role of filoviral glycoproteins. J. Gen. Virol. 82:2839-2848.
20. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Penaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Gunther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300:1394-1399.
21. Florkiewicz RZ, Rose JK. 1984. A cell line expressing vesicular stomatitis virus glycoprotein fuses at low pH. Science 225:721-723.
22. Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, Sol-Foulon N, Le Roux K, Prevost MC, Fsihi H, Frenkiel MP, Blanchet F, Afonso PV, Ceccaldi PE, Ozden S, Gessain A, Schuffenecker I, Verhasselt B, Zamborlini A, Saib A, Rey FA, Arenzana-Seisdedos F, Despres P, Michault A, Albert ML, Schwartz O. 2007. Characterization of reemerging chikungunya virus. PLoS Pathog. 3:e89. doi:10.1371/journal.ppat.0030089.
23. Diederich S, Thiel L, Maisner A. 2008. Role of endocytosis and cathepsin-mediated activation in Nipah virus entry. Virology 375:391-400.
24. Holland AU, Munk C, Lucero GR, Nguyen LD, Landau NR. 2004. Alpha-complementation assay for HIV envelope glycoprotein-mediated fusion. Virology 319:343-352.
25. Moosmann P, Rusconi S. 1996. Alpha complementation of LacZ in mammalian cells. Nucleic Acids Res. 24:1171-1172.
26. Ullmann A, Jacob F, Monod J. 1967. Characterization by in vitro complementation of a peptide corresponding to an operator-proximal segment of the beta-galactosidase structural gene of Escherichia coli. J. Mol. Biol. 24:339-343.
27. Aljofan M, Saubern S, Meyer AG, Marsh G, Meers J, Mungall BA. 2009. Characteristics of Nipah virus and Hendra virus replication in different cell lines and their suitability for antiviral screening. Virus Res. 142:92-99.
28. Wikan N, Sakoonwatanyoo P, Ubol S, Yoksan S, Smith DR. 2012. Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage. PLoS One 7:e31102. doi:10.1371/journal.pone .0031102.
29. Kononchik JP, Jr, Hernandez R, Brown DT. 2011. An alternative pathway for alphavirus entry. Virol. J. 8:304. doi:10.1186/1743-422X-8-304.
30. Roberts PC, Kipperman T, Compans RW. 1999. Vesicular stomatitis virus G protein acquires pH-independent fusion activity during transport in a polarized endometrial cell line. J. Virol. 73:10447-10457.
31. Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y. 1991. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 266:17707-17712.
32. Klimstra WB, Nangle EM, Smith MS, Yurochko AD, Ryman KD. 2003. DC-SIGN and L-SIGN can act as attachment receptors for alphaviruses and distinguish between mosquito cell-and mammalian cell-derived viruses. J. Virol. 77:12022-12032.
33. Gramberg T, Soilleux E, Fisch T, Lalor PF, Hofmann H, Wheeldon S, Cotterill A, Wegele A, Winkler T, Adams DH, Pohlmann S. 2008. Interactions of LSECtin and DC-SIGN/DC-SIGNR with viral ligands: differential pH dependence, internalization and virion binding. Virology 373:189-201.
34. Feinberg H, Mitchell DA, Drickamer K, Weis WI. 2001. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR. Science 294:2163-2166.
35. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL, Daszak P. 2008. Global trends in emerging infectious diseases. Nature 451:990-993.
36. Colman PM, Lawrence MC. 2003. The structural biology of type I viral membrane fusion. Nat. Rev. Mol. Cell Biol. 4:309-319.
37. Bourhy H, Cowley JA, Larrous F, Holmes EC, Walker PJ. 2005. Phylogenetic relationships among rhabdoviruses inferred using the L polymerase gene. J. Gen. Virol. 86:2849-2858.
38. Ogbu O, Ajuluchukwu E, Uneke CJ. 2007. Lassa fever in West African sub-region: an overview. J. Vector Borne Dis. 44:1-11.
39. Smith I, Wang LF. 2013. Bats and their virome: an important source of emerging viruses capable of infecting humans. Curr. Opin. Virol. 3:84-91.
40. Fredericksen BL, Whitt MA. 1996. Mutations at two conserved acidic amino acids in the glycoprotein of vesicular stomatitis virus affect pHdependent conformational changes and reduce the pH threshold for membrane fusion. Virology 217:49-57.
41. Tsetsarkin KA, McGee CE, Higgs S. 2011. Chikungunya virus adaptation to Aedes albopictus mosquitoes does not correlate with acquisition of cholesterol dependence or decreased pH threshold for fusion reaction. Virol. J. 8:376. doi:10.1186/1743-422X-8-376